↗6 Form 4 rows in the window
Covers original filings from Jul 31, 2026 to Oct 28, 2026. Older trades and amendments are in the SEC history.
$0.00Bought on the market
$36.5MSold on the market
1Companies
Oct 20, 2026Latest filing
| Company | Title | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 20, 202617:42 | Oct 16, 2026 | ROIVRoivant Sciences Ltd. | President & CIO, Director | F · Tax | $33.53 | −19,976 | 18,563,884 | -0% | $670K | ||
| Oct 2, 202617:38 | Sep 30, 2026 | ROIVRoivant Sciences Ltd. | President & CIO, Director | F · Tax | $36.57 | −46,879 | 18,583,860 | -0% | $1.7M | ||
| Aug 21, 202621:00 | Aug 21, 2026from Aug 19, 2026 | ROIVRoivant Sciences Ltd. | President & CIO, Director | S · Sell | $36.88 | −335,174 | 18,630,739 | -2% | −$12.4M | ||
| Aug 21, 202621:00 | Aug 21, 2026from Aug 19, 2026 | ROIVRoivant Sciences Ltd. | President & CIO, Director | M · Exercise | $3.85 | +335,174 | 18,775,495 | +2% | $1.3M | ||
| Aug 18, 202621:00 | Aug 18, 2026from Aug 14, 2026 | ROIVRoivant Sciences Ltd. | President & CIO, Director | S · Sell | $36.34 | −664,826 | 18,630,739 | -3% | −$24.2M | ||
| Aug 18, 202621:00 | Aug 18, 2026from Aug 14, 2026 | ROIVRoivant Sciences Ltd. | President & CIO, Director | M · Exercise | $3.85 | +664,826 | 18,662,540 | +4% | $2.6M |